| 1:30 – 1:55: Joel Parker, LifeEdit Therapeutics: BCB at LifeEdit Therapeutics
1:55 – 2:20: Anupama Reddy, Vindhya Data Science: Biomarker Development to Enhance Precision Medicine, Translating ‘Omics Signatures to the Clinic
2:20 – 2:45: Victor Weigman, Bioskryb Genomics: Understanding Molecular Impacts of Gene Therapies Through Multi-Omic Profiling of Individual Cells
Coffee Break
2:55 – 3:20: Marshall Thompson, Rare Cancer Research Foundation: Direct Patient Participation in Oncology Research as a Catalyst for Innovation
3:20 – 3:45: Sara Selitsky, Tempus AI: Development of a Prognostic Signature Through Molecular Subtyping of a Rare Squamous Cancer
3:45 – 4:10: Nicholas Dietrich, Kriya Therapeutics: Next Generation Sequencing and Gene Therapy Product Development
4:10 – 4:35: Mariano Alvarez, Avalo: Interpretable Machine Learning for Discovery and Prediction Tasks in Commerical Breeding Programs
Coffee Break
4:45 – 5:10: Mark Lovern, InSilicoTrials: Introduction to Model-Informed Drug Development
5:10 – 5:35: Umut Eser, Weave: Challenges and Opportunities of Modernizing the Drug Development Process with AI
5:35 – 6:00: Marcel Frenkel, Ten63: Molecular Voxel Theory, Exploring Vast Chemical and Conformational Space to Drug the Undruggable |
